Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury
Open Access
- 27 September 2013
- journal article
- research article
- Published by Springer Nature in Genome Medicine
- Vol. 5 (9) , 85-3
Abstract
Biomarkers of drug-induced liver injury (DILI) are essential for the diagnosis of severe cases of DILI in clinical trials and clinical practice, but the currently used biomarker paradigm detects damage after it has occurred and has limited prognostic value. The development of new biomarker strategies that improve the diagnosis of DILI by providing increased specificity and/or by identifying individual patients who are at risk for DILI is therefore crucial. See related Research, http://genomemedicine.com/content/5/9/86Keywords
This publication has 10 references indexed in Scilit:
- Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injuryGenome Medicine, 2013
- Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosisBritish Journal of Clinical Pharmacology, 2013
- Development of Blood Biomarkers for Drug-Induced Liver Injury: An Evaluation of Their Potential for Risk Assessment and DiagnosticsMolecular Diagnosis & Therapy, 2013
- Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to HospitalHepatology, 2013
- Assessment of Emerging Biomarkers of Liver Injury in Human SubjectsToxicological Sciences, 2013
- Limited contribution of common genetic variants to risk for liver injury due to a variety of drugsPharmacogenetics and Genomics, 2012
- RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicityJournal of Hepatology, 2012
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- Circulating apoptotic and necrotic cell death markers in patients with acute liver injuryLiver International, 2011
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinNature Genetics, 2009